Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-25T08:36:23.323Z Has data issue: false hasContentIssue false

Cahpter 20 - Contraception for the Perimenopausal Woman

Published online by Cambridge University Press:  18 June 2020

By
Paula Briggs  and
Nicola Kersey
Edited by
Nicholas Panay ,
Paula Briggs  and
Gabor T. Kovacs
Nicholas Panay
Affiliation:
Queen Charlotte's & Chelsea Hospital, London
Paula Briggs
Affiliation:
Liverpool Women's NHS Foundation Trust
Gabor T. Kovacs
Affiliation:
Monash University, Victoria
Get access

Summary

The World Health Organization (WHO) defines menopause as the permanent cessation of menstruation due to loss of ovarian follicular activity [1]. It is a retrospective diagnosis, which can only be made with certainty after 12 months of spontaneous amenorrhoea. The average age of menopause in UK women is 51 [2].

Type
Chapter
Information
Managing the Menopause , pp. 194 - 207
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. Research on the Menopause in the 1990s: Report of a WHO Scientific Group. 1996. World Health Organization.Google Scholar
Gold, EB, Crawford, SL, Avis, NE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol 2013 Jul;1178(1):70–83.CrossRefGoogle Scholar
Baldwin, MK, Jensen, JT. Contraception during the perimenopause. Maturitas 2013;76:235–42.CrossRefGoogle ScholarPubMed
Faculty of Sexual and Reproductive Healthcare. Contraception for Women Aged over 40 Years. 2010. Faculty of Sexual and Reproductive Healthcare. www.fsrh.org/documents/cec‐ceu‐guidance‐womenover40‐jul‐2010Google Scholar
Kenny, LC, Lavender, T, McNamee, R, O’Neill, SM, Mills, T, Khashan, AS. Advanced maternal age and adverse pregnancy outcome: Evidence from a large contemporary cohort. PLoS ONE 2013;8(2):e56583.CrossRefGoogle ScholarPubMed
Wellings, K, Jones, KG, Mercer, CH, Tanton, C, Clifton, S, Datta, J, et al. The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal‐3). Lancet 2013;382:1807–16.Google Scholar
Gebbie, AE, Glasier, A, Sweeting, V. Incidence of ovulation in perimenopausal women before and during hormone replacement therapy. Contraception 1995;52:221–2.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. Clinical knowledge summaries: menopause. 2013. http://cks.nice.org.uk/menopauseGoogle Scholar
Faculty of Sexual and Reproductive Healthcare (FSRH). UK Medical Eligibility Criteria for Contraceptive Use (UKMEC). 2016. www.fsrh.org/standards-and-guidance/external/ukmec-2016-digital-version/Google Scholar
National Institute for Health and Care Excellence. Clinical knowledge summaries: contraception – assessment. 2016. https://cks.nice.org.uk/contraception-assessmentGoogle Scholar
Lopez, LM, Grimes, DA, Gallo, MF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2013;4:CD003552.Google Scholar
National Institute for Health and Care Excellence. Heavy Menstrual Bleeding: Assessment and Management. 2018. NICE. https://nice.org.uk/guidance/ng88Google Scholar
Nappi, C, Bifulco, G, Tommaselli, GA, Gargano, V, Di Carlo, C. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012;86(6):606–21.Google Scholar
European Medicines Agency. Press release: Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks. 2013. www.ema.europa.eu/en/news/benefits-combined-hormonal-contraceptives-chcs-continue-outweigh-risks-chmp-endorses- prachormonal_contraceptives/European_Commission_ nal_decision/WC500160277.pdfGoogle Scholar
Beaber, E, Buist, DS, Barlow, WE, Malone, KE, Reed, SD, Li, CL. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res 2014;74:4078–89.Google Scholar
Trussell, J. Contraceptive failure in the United States. Contraception 2011;83(5):397–404.CrossRefGoogle ScholarPubMed
Weill, A, Dalichampt, M, Raguideau, F, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ Clin Res Ed 2016;353:i2002.Google Scholar
Dinger, J, Do Minh, T, Heinemann, K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception 2016;94(4):328–39.CrossRefGoogle ScholarPubMed
Faculty of Sexual and Reproductive Healthcare. Progestogen‐only pills. 2015. www.fsrh.org/documents/ceuguidanceprogestogenonlypillsGoogle Scholar
Faculty of Sexual and Reproductive Healthcare (FSRH). Progestogen-only implants. 2014. www.fsrh.org/documents/cec-ceu-guidance-implants-feb-2014/Google Scholar
Lakha, F, Glasier, AF. Continuation rates of implanon in the UK: data from an observational study in a clinical setting. Contraception 2006;74:287–9.CrossRefGoogle ScholarPubMed
Pfizer Ltd. Depo‐Provera 150 mg/ml injection. 2016. www.medicines.org.uk/emc/medicine/11121Google Scholar
Faculty of Sexual and Reproductive Healthcare. Progestogen‐only injectable contraception. 2014. www.fsrh.org/documents/cec‐ceu‐guidance‐injectables‐dec‐2014Google Scholar
Faculty of Sexual and Reproductive Healthcare (FSRH). Intrauterine contraception. 2015. www.fsrh.org/standards-and-guidance/documents/ceuguidanceintrauterinecontraception/Google Scholar
Office for National Statistics. Statistical Bulletin: conceptions in England and Wales. 2012. http://webarchive.nationalarchives.gov.uk/20160109214216/www.ons.gov.uk/ons/rel/vsob1/conception-statistics-england-and-wales/2010/2010-conceptions-statistical-bulletin.html?format=printGoogle Scholar
Public Health England. National STI surveillance data tables 2015 – Table 20.8. 2015. www.gov.uk/government/uploads/system/uploads/attachment_data/file/534564/2015_Table_8_Attendances_by_gender__sexual_risk___age_group__2011-2015.pdfGoogle Scholar
Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists. FSRH clinical guidance: male and female sterilisation – September 2014. 2014.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×